Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.

To expand, Aurora has been focusing on selling medical marijuana products internationally, where it can sell at higher prices and produce better margins for the business. It was the international ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Aurora Cannabis Inc. (ACB) been one of those stocks this ...

EDMONTON, AB, Feb. 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille ...

Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical ...

Aurora Cannabis produces and sells a variety of cannabis products, including dried cannabis, oils, capsules, and topical treatments, primarily for medical patients. It also manufactures and sells ...

This expansion marks another meaningful step in Aurora’s deep commitment to offering patients a diverse range of high-quality, premium medical cannabis products to meet their various needs and ...